Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q3 2020 · 10-Q
Revenue$258.97M$258.97M+4.7% vs Q3 2019 Net Income$29.90M$29.90MN/M vs Q3 2019 EPS Diluted$0.58$0.58+65.7% vs Q3 2019 Gross Profit$128,050,000+15.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$79,282,000+36.3% Free Cash Flowderived$58,892,000+103.6% Margins · derivedGross margin49.4%+4.5 pt vs Q3 2019
Operating margin15.8%+4.3 pt vs Q3 2019
Net margin11.5%+15.0 pt vs Q3 2019
ended Dec 28, 2019 · filed Feb 4, 2020 · 38 d after period end